H&E staining results showed that there was obvious macrovesicular steatosis in the livers of WD-fed ApoE-/- mice compared to ND mice, while leflunomide treatment significantly improved hepatic steatosis and protected the hepatocytes compared to the WD group (Figure 2A). This evidence concerns the gene APOE and fatty liver disease.